LP
Ligand Pharmaceuticals Incorporated
🇺🇸XNAS.LGNDUnited StatesHealthcare
$275.20USDup +2.60 (+0.95%)ClosedEnd of day1:26 AM
Price$275.20+2.60 (+0.95%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US53220K5048
- CUSIP
- 53220K199
Company
- Employees
- 47
- Headquarters
- Jupiter, United States
- Website
- https://www.ligand.com
- CEO
- Mr. Todd C. Davis Ph.D.
Market
- Shares outstanding
- 19.9M
- Market cap
- $5.49B
Key dates
- Next earnings
- Nov 5, 2026
Highlights
- Market cap
- $5.43B
- EPS LTM
- $9.03
- P/E LTM
- 35.00
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $290.54M+54.89%up year on year
- Net income
- $197.22M+359.97%up year on year
- Gross margin
- 98.58%+12.42%up year on year
- Free cash flow
- $131.37M+229.23%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.